Search research articles
Contact Us
Filters
Showing results (911-920 of 946) with videos related to
Page
of 95
Sort By:
Journal of the National Cancer Institute
|
October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort
Fergus Keane, Catherine O'Connor, Drew Moss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2020
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection
Wungki Park, Jiapeng Chen, Joanne F Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2022
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial
Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2017
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype
Maeve A Lowery, Emmet J Jordan, Olca Basturk, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 6, 2025
Fecal Short-Chain Fatty Acids Vary by Sex and Amyloid Status
Jessamine F Kuehn, Qijun Zhang, Margo B Heston, et al.
Nature Communications
|
September 7, 2017
A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission
David A Baker, Lindsay B Stewart, Jonathan M Large, et al.
Cancer Discovery
|
October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition
James J Harding, Maeve A Lowery, Alan H Shih, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 22, 2025
Fecal short-chain fatty acids vary by sex and amyloid status
Jessamine F Kuehn, Qijun Zhang, Margo B Heston, et al.
Proteins
|
August 24, 2019
Target highlights in CASP13: Experimental target structures through the eyes of their authors
Rosalba Lepore, Andriy Kryshtafovych, Markus Alahuhta, et al.
JAMA Oncology
|
November 1, 2019
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial
Andrea Cercek, Thomas Boerner, Benjamin R Tan, et al.
Page
of 95
Search research articles
Search
Showing results (911-920 of 946) with videos related to
Sort By:
Page
of 95
Journal of the National Cancer Institute
|
October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort
Fergus Keane, Catherine O'Connor, Drew Moss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2020
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection
Wungki Park, Jiapeng Chen, Joanne F Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2022
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial
Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2017
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype
Maeve A Lowery, Emmet J Jordan, Olca Basturk, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 6, 2025
Fecal Short-Chain Fatty Acids Vary by Sex and Amyloid Status
Jessamine F Kuehn, Qijun Zhang, Margo B Heston, et al.
Nature Communications
|
September 7, 2017
A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission
David A Baker, Lindsay B Stewart, Jonathan M Large, et al.
Cancer Discovery
|
October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition
James J Harding, Maeve A Lowery, Alan H Shih, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 22, 2025
Fecal short-chain fatty acids vary by sex and amyloid status
Jessamine F Kuehn, Qijun Zhang, Margo B Heston, et al.
Proteins
|
August 24, 2019
Target highlights in CASP13: Experimental target structures through the eyes of their authors
Rosalba Lepore, Andriy Kryshtafovych, Markus Alahuhta, et al.
JAMA Oncology
|
November 1, 2019
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial
Andrea Cercek, Thomas Boerner, Benjamin R Tan, et al.
Page
of 95